2022-11-03 |
2022-11-01 |
PS
Planned sale
|
Grossi Federico
Chief Medical Officer
Officer
|
2,500
-2.4%
60.83
152,075
USD
|
2,500
-2.4%
|
60.83
|
152,075
USD
|
|
2022-11-03 |
2022-11-01 |
PS
Planned sale
|
Dunlop A. Sinclair
Non-Executive Director
|
500
-0.4%
60.83
30,415
USD
|
500
-0.4%
|
60.83
|
30,415
USD
|
|
2022-10-17 |
2022-10-14 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
59.31
74,138
USD
|
1,250
-0.5%
|
59.31
|
74,138
USD
|
|
2022-10-11 |
2022-10-10 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.2%
57.50
690,000
USD
|
12,000
-1.2%
|
57.50
|
690,000
USD
|
|
2022-10-05 |
2022-10-03 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-10.4%
66.69
333,450
USD
|
5,000
-10.4%
|
66.69
|
333,450
USD
|
|
2022-10-05 |
2022-10-03 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
2,500
-2.4%
66.69
166,725
USD
|
2,500
-2.4%
|
66.69
|
166,725
USD
|
|
2022-09-16 |
2022-09-15 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
66.00
82,500
USD
|
1,250
-0.5%
|
66.00
|
82,500
USD
|
|
2022-09-12 |
2022-09-08 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.2%
63.98
767,760
USD
|
12,000
-1.2%
|
63.98
|
767,760
USD
|
|
2022-09-08 |
2022-09-08 |
S
Sale
|
Dunlop A. Sinclair
Non-Executive Director
|
15,000
-5.9%
65.00
975,000
USD
|
15,000
-5.9%
|
65.00
|
975,000
USD
|
|
2022-09-07 |
2022-09-06 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-10.4%
60.38
301,900
USD
|
5,000
-10.4%
|
60.38
|
301,900
USD
|
|
2022-09-02 |
2022-09-01 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
2,500
-2.3%
60.30
150,750
USD
|
2,500
-2.3%
|
60.30
|
150,750
USD
|
|
2022-08-18 |
2022-08-17 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
69.50
347,500
USD
|
5,000
-14.6%
|
69.50
|
347,500
USD
|
|
2022-08-16 |
2022-08-15 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
12,500
-22.6%
69.00
862,500
USD
|
12,500
-22.6%
|
69.00
|
862,500
USD
|
|
2022-08-16 |
2022-08-15 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
67.21
84,013
USD
|
1,250
-0.5%
|
67.21
|
84,013
USD
|
|
2022-08-12 |
2022-08-11 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
12,500
-22.6%
67.00
837,500
USD
|
12,500
-22.6%
|
67.00
|
837,500
USD
|
|
2022-08-12 |
2022-08-11 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
67.00
335,000
USD
|
5,000
-14.6%
|
67.00
|
335,000
USD
|
|
2022-08-12 |
2022-08-11 |
S
Sale
|
Dunlop A. Sinclair
Non-Executive Director
|
30,000
-10.5%
65.63
1,968,900
USD
|
30,000
-10.5%
|
65.63
|
1,968,900
USD
|
|
2022-08-09 |
2022-08-08 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
64.50
322,500
USD
|
5,000
-14.6%
|
64.50
|
322,500
USD
|
|
2022-08-09 |
2022-08-08 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
12,500
-22.6%
65.00
812,500
USD
|
12,500
-22.6%
|
65.00
|
812,500
USD
|
|
2022-08-09 |
2022-08-08 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.3%
62.50
750,000
USD
|
12,000
-1.3%
|
62.50
|
750,000
USD
|
|
2022-08-08 |
2022-08-04 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
62.00
310,000
USD
|
5,000
-14.6%
|
62.00
|
310,000
USD
|
|
2022-08-08 |
2022-08-04 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-12.7%
59.50
297,500
USD
|
5,000
-12.7%
|
59.50
|
297,500
USD
|
|
2022-08-04 |
2022-08-03 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-11.7%
56.43
282,150
USD
|
5,000
-11.7%
|
56.43
|
282,150
USD
|
|
2022-08-02 |
2022-08-01 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
2,500
-2.3%
55.99
139,975
USD
|
2,500
-2.3%
|
55.99
|
139,975
USD
|
|
2022-07-28 |
2022-07-27 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
57.00
285,000
USD
|
5,000
-14.6%
|
57.00
|
285,000
USD
|
|
2022-07-21 |
2022-07-19 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
56.42
282,100
USD
|
5,000
-14.6%
|
56.42
|
282,100
USD
|
|
2022-07-18 |
2022-07-15 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
46.33
57,913
USD
|
1,250
-0.5%
|
46.33
|
57,913
USD
|
|
2022-07-12 |
2022-07-11 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-10.4%
48.42
242,100
USD
|
5,000
-10.4%
|
48.42
|
242,100
USD
|
|
2022-07-12 |
2022-07-08 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.3%
47.95
575,400
USD
|
12,000
-1.3%
|
47.95
|
575,400
USD
|
|
2022-06-29 |
2022-06-27 |
S
Sale
|
Dunlop A. Sinclair
Non-Executive Director
|
1,341
-50.0%
46.79
62,743
USD
|
1,341
-50.0%
|
46.79
|
62,743
USD
|
|
2022-06-24 |
2022-06-23 |
S
Sale
|
Dunlop A. Sinclair
Non-Executive Director
|
15,000
-5.0%
45.00
675,000
USD
|
15,000
-5.0%
|
45.00
|
675,000
USD
|
|
2022-06-23 |
2022-06-22 |
S
Sale
|
Watson David O.
General Counsel
Officer
|
10,000
-8.0%
44.51
445,140
USD
|
10,000
-8.0%
|
44.51
|
445,140
USD
|
|
2022-06-22 |
2022-06-17 |
S
Sale
|
Brown Victoria L.
Program Team Lead
Officer
|
2,698
-9.7%
45.00
121,410
USD
|
2,698
-9.7%
|
45.00
|
121,410
USD
|
|
2022-06-21 |
2022-06-16 |
S
Sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
10,000
-25.5%
41.79
417,850
USD
|
10,000
-25.5%
|
41.79
|
417,850
USD
|
|
2022-06-17 |
2022-06-15 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
39.29
49,113
USD
|
1,250
-0.5%
|
39.29
|
49,113
USD
|
|
2022-06-09 |
2022-06-08 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.3%
44.09
529,080
USD
|
12,000
-1.3%
|
44.09
|
529,080
USD
|
|
2022-06-02 |
2022-06-01 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
2,500
-2.2%
41.78
104,450
USD
|
2,500
-2.2%
|
41.78
|
104,450
USD
|
|
2022-05-31 |
2022-05-27 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
10,000
-19.9%
43.00
430,000
USD
|
10,000
-19.9%
|
43.00
|
430,000
USD
|
|
2022-05-17 |
2022-05-16 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
39.18
48,975
USD
|
1,250
-0.5%
|
39.18
|
48,975
USD
|
|
2022-05-03 |
2022-05-02 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
2,500
-2.2%
43.56
108,900
USD
|
2,500
-2.2%
|
43.56
|
108,900
USD
|
|
2022-05-02 |
2022-04-29 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
4,000
-0.4%
44.43
177,720
USD
|
4,000
-0.4%
|
44.43
|
177,720
USD
|
|
2022-04-27 |
2022-04-25 |
PS
Planned sale
|
Watson David O.
General Counsel
Officer
|
5,000
-3.8%
50.00
250,000
USD
|
5,000
-3.8%
|
50.00
|
250,000
USD
|
|
2022-04-22 |
2022-04-20 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
7,000
-19.7%
52.53
367,710
USD
|
7,000
-19.7%
|
52.53
|
367,710
USD
|
|
2022-04-18 |
2022-04-14 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
50.90
63,625
USD
|
1,250
-0.5%
|
50.90
|
63,625
USD
|
|
2022-04-06 |
2022-04-05 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
609
-1.2%
60.09
36,593
USD
|
609
-1.2%
|
60.09
|
36,593
USD
|
|
2022-04-05 |
2022-04-04 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
1,249
-2.3%
57.81
72,198
USD
|
1,249
-2.3%
|
57.81
|
72,198
USD
|
|
2022-04-05 |
2022-04-04 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
1,437
-2.6%
56.86
81,714
USD
|
1,437
-2.6%
|
56.86
|
81,714
USD
|
|
2022-04-05 |
2022-04-04 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
818
-1.5%
55.84
45,677
USD
|
818
-1.5%
|
55.84
|
45,677
USD
|
|
2022-04-04 |
2022-04-01 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
11,496
-18.0%
55.05
632,855
USD
|
11,496
-18.0%
|
55.05
|
632,855
USD
|
|
2022-03-17 |
2022-03-15 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
375
-0.3%
39.57
14,839
USD
|
375
-0.3%
|
39.57
|
14,839
USD
|
|
2022-03-17 |
2022-03-15 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
39.57
49,463
USD
|
1,250
-0.5%
|
39.57
|
49,463
USD
|
|
2022-03-02 |
2022-03-01 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
375
-0.3%
43.53
16,324
USD
|
375
-0.3%
|
43.53
|
16,324
USD
|
|
2022-02-16 |
2022-02-15 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
375
-0.4%
45.43
17,036
USD
|
375
-0.4%
|
45.43
|
17,036
USD
|
|
2022-02-16 |
2022-02-15 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.2%
45.43
56,788
USD
|
1,250
-0.2%
|
45.43
|
56,788
USD
|
|
2022-02-14 |
2022-02-11 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
1,666
-3.1%
46.80
77,969
USD
|
1,666
-3.1%
|
46.80
|
77,969
USD
|
|
2022-02-14 |
2022-02-10 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
10,000
-15.8%
50.00
500,000
USD
|
10,000
-15.8%
|
50.00
|
500,000
USD
|
|
2022-02-10 |
2022-02-08 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
10,000
-15.7%
45.00
450,000
USD
|
10,000
-15.7%
|
45.00
|
450,000
USD
|
|
2022-02-02 |
2022-02-01 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
375
-0.4%
40.58
15,218
USD
|
375
-0.4%
|
40.58
|
15,218
USD
|
|
2022-02-01 |
2022-01-31 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
1,233
-2.2%
38.47
47,434
USD
|
1,233
-2.2%
|
38.47
|
47,434
USD
|
|
2022-01-19 |
2022-01-14 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.2%
40.56
50,700
USD
|
1,250
-0.2%
|
40.56
|
50,700
USD
|
|
2022-01-19 |
2022-01-14 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
375
-0.5%
40.56
15,210
USD
|
375
-0.5%
|
40.56
|
15,210
USD
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
375
-0.5%
47.31
17,741
USD
|
375
-0.5%
|
47.31
|
17,741
USD
|
|
2021-12-23 |
2021-12-22 |
S
Sale
|
Watson David O.
General Counsel
Officer
|
300
-0.3%
48.58
14,573
USD
|
300
-0.3%
|
48.58
|
14,573
USD
|
|
2021-12-23 |
2021-12-22 |
S
Sale
|
Watson David O.
General Counsel
Officer
|
5,097
-4.5%
47.86
243,917
USD
|
5,097
-4.5%
|
47.86
|
243,917
USD
|
|
2021-12-23 |
2021-12-22 |
S
Sale
|
Watson David O.
General Counsel
Officer
|
5,174
-4.7%
47.72
246,883
USD
|
5,174
-4.7%
|
47.72
|
246,883
USD
|
|
2021-12-17 |
2021-12-15 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
3,000
-0.4%
42.88
128,640
USD
|
3,000
-0.4%
|
42.88
|
128,640
USD
|
|
2021-12-17 |
2021-12-15 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
375
-0.5%
42.88
16,080
USD
|
375
-0.5%
|
42.88
|
16,080
USD
|
|
2021-12-03 |
2021-12-01 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
375
-0.6%
42.40
15,900
USD
|
375
-0.6%
|
42.40
|
15,900
USD
|
|
2021-11-18 |
2021-11-18 |
B
Purchase
|
Morningside Venture Investments Ltd
Large shareholder
|
250,000
+2.0%
40.00
10,000,000
USD
|
250,000
+2.0%
|
40.00
|
10,000,000
USD
|
|
2021-11-17 |
2021-11-15 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
3,000
-0.4%
43.50
130,500
USD
|
3,000
-0.4%
|
43.50
|
130,500
USD
|
|
2021-11-17 |
2021-11-15 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
625
-1.0%
43.50
27,188
USD
|
625
-1.0%
|
43.50
|
27,188
USD
|
|
2021-11-17 |
2021-11-04 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
3,000
-0.4%
35.00
105,000
USD
|
3,000
-0.4%
|
35.00
|
105,000
USD
|
|
2021-11-02 |
2021-11-01 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
625
-1.0%
30.70
19,188
USD
|
625
-1.0%
|
30.70
|
19,188
USD
|
|
2021-10-15 |
2021-10-14 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
750
-1.1%
34.57
25,928
USD
|
750
-1.1%
|
34.57
|
25,928
USD
|
|
2021-10-05 |
2021-10-01 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
750
-1.1%
33.26
24,945
USD
|
750
-1.1%
|
33.26
|
24,945
USD
|
|